8.3 levetiracetam 8.4 sodium valproate 8.5 topiramate 8.6 other. Data NA/ No. item Criteria Yes No Exceptionsa no. If there were absence or myoclonic seizures, or juvenile myoclonic 9 epilepsy was suspected, were any of the following offered? 9.1 carbamazepine 9.2 gabapentin 9.3 oxcarbazepine 9.4 phenytoin 9.5 pregabalin 9.5 tiagabine 9.6 vigabatrin. a Circle exception codes as appropriate. Details of exceptions are listed at the end of the patient data collection tool. Exception codes B sodium valproate is unsuitable – C the person has myoclonic seizures – D the person is suspected of having juvenile myoclonic epilepsy – Criteria for Epilepsy: pharmacological treatment by seizure type Absence seizures Ethosuximide or sodium valproate should be offered as first-line Criterion 10 treatment. Exceptions None
8.3 levetiracetam 8.4 sodium valproate 8.5 topiramate 8.6 other. No. Data item no. Criteria Yes No NA/ Exceptionsa 9 If there were absence or myoclonic seizures, or juvenile myoclonic epilepsy was suspected, were any of the following offered? 9.1 carbamazepine 9.2 gabapentin 9.3 oxcarbazepine 9.4 phenytoin 9.5 pregabalin 9.5 tiagabine 9.6 vigabatrin. a Circle exception codes as appropriate. Details of exceptions are listed at the end of the patient data collection tool. Exception codes B – sodium valproate is unsuitable C – the person has myoclonic seizures D – the person is suspected of having juvenile myoclonic epilepsy Criteria for Epilepsy: pharmacological treatment by seizure type Absence seizures Criterion 10 Ethosuximide or sodium valproate should be offered as first-line treatment. Exceptions None